Concepedia

Qing‐Tian Niu

QN

Statistics

Publications

20

Citations

3.2K

H-Index

20

Active since

2004

Affiliations

Amgen (United States)(Current)

UCB Pharma (United Kingdom)

Qing‐Tian Niu is an author at Amgen (United States) specializing in bone metabolism, medicine, and bone physiology.

Publications per year

2004–2018

20

Publications

20

Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength

Xiaodong Li, Michael S. Ominsky, Qing‐Tian Niu et al. · Journal of Bone and Mineral Research · 2008 · 938 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis

Xiaodong Li, Michael S. Ominsky, Kelly Warmington et al. · Journal of Bone and Mineral Research · 2008 · 784 citations

Medicine, Biochemistry, Endocrinology +16

Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats

Xiaodong Li, Kelly Warmington, Qing‐Tian Niu et al. · Journal of Bone and Mineral Research · 2010 · 234 citations

Medicine, Orthopaedic Surgery, Bone Augmentation +16

Tissue-Level Mechanisms Responsible for the Increase in Bone Formation and Bone Volume by Sclerostin Antibody

Michael S. Ominsky, Qing‐Tian Niu, Chaoyang Li et al. · Journal of Bone and Mineral Research · 2013 · 165 citations · Full text

Medicine, Endocrinology, Bone Augmentation +16

Sustained Modeling-Based Bone Formation During Adulthood in Cynomolgus Monkeys May Contribute to Continuous BMD Gains With Denosumab

Michael S. Ominsky, Cesar Libanati, Qing‐Tian Niu et al. · Journal of Bone and Mineral Research · 2015 · 121 citations · Full text

Medicine, Endocrinology, Pharmacology +17

1–5 of 20